Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Hull

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 10, 2009
Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomasR J Cuthbert, J M Wilson, N Scott, et al.
BMJ (Clinical Research Ed.)|July 11, 1992
Percutaneous endoscopic gastrostomy feedingF E Murray, M A Hull, J Rawlings, et al.
Gut|February 1, 1997
Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulcerationM A Hull, A Knifton, B Filipowicz, et al.
Gut|November 21, 1998
Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosaM A Hull, J L Brough, D G Powe, et al.
Gut|June 13, 2006
Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastasesC R Chalmers, D J Wilson, J Ward, et al.
Clinical & Experimental Metastasis|February 24, 2001
Cyclooxygenase-2 expression in colorectal cancer liver metastasesM A Hull, S W Fenwick, K S Chapple, et al.
British Journal of Cancer|April 3, 1999
Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min miceM A Hull, J K Booth, A Tisbury, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 17, 2002
Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988R H Skelly, R M Kupfer, M E Metcalfe, et al.
Lancet (London, England)|April 3, 1993
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomyM A Hull, J Rawlings, F E Murray, et al.
Gut|September 13, 2003
Fulminant Crohn's colitis after allogeneic stem cell transplantationS A Sonwalkar, R M James, T Ahmad, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 10, 2009
Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomasR J Cuthbert, J M Wilson, N Scott, et al.
BMJ (Clinical Research Ed.)|July 11, 1992
Percutaneous endoscopic gastrostomy feedingF E Murray, M A Hull, J Rawlings, et al.
Gut|February 1, 1997
Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulcerationM A Hull, A Knifton, B Filipowicz, et al.
Gut|November 21, 1998
Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosaM A Hull, J L Brough, D G Powe, et al.
Gut|June 13, 2006
Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastasesC R Chalmers, D J Wilson, J Ward, et al.
Clinical & Experimental Metastasis|February 24, 2001
Cyclooxygenase-2 expression in colorectal cancer liver metastasesM A Hull, S W Fenwick, K S Chapple, et al.
British Journal of Cancer|April 3, 1999
Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min miceM A Hull, J K Booth, A Tisbury, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 17, 2002
Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988R H Skelly, R M Kupfer, M E Metcalfe, et al.
Lancet (London, England)|April 3, 1993
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomyM A Hull, J Rawlings, F E Murray, et al.
Gut|September 13, 2003
Fulminant Crohn's colitis after allogeneic stem cell transplantationS A Sonwalkar, R M James, T Ahmad, et al.
Pageof 4